Ruxolitinib
Showing 26 - 50 of 345
A PMS of JakaviĀ® in Steroid-Refractory Graft-versus-Host Disease
Not yet recruiting
- Graft-versus-Host Disease
- ruxolitinib
- (no location specified)
Jan 11, 2023
Acute-graft-versus-host Disease Trial in Minneapolis (Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids)
Not yet recruiting
- Acute-graft-versus-host Disease
- Ruxolitinib 10 MG Oral Tablet
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)
Recruiting
- Chronic Hand Dermatitis
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
Aug 9, 2022
Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Long-term Follow-up
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Atopic Dermatitis (AD) Trial (Ruxolitinib Cream)
Not yet recruiting
- Atopic Dermatitis (AD)
- Ruxolitinib Cream
- (no location specified)
Jul 8, 2022
Assess Real-World Patient-Reported Outcomes With Fedratinib for
Recruiting
- Myelofibrosis
-
City, State, AustriaLocal Institution
Dec 16, 2022
Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)
Recruiting
- Hematopoietic Stem Cell Transplant (HSCT)
- Bronchiolitis Obliterans (BO)
- Ruxolitinib
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 6, 2022
Myelofibrosis Trial in Jinan (Ruxolitinib)
Recruiting
- Myelofibrosis
- Ruxolitinib
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jul 3, 2022
Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)
Recruiting
- Bronchiolitis Obliterans Syndrome
- Hematologic Malignancy
- Ruxolitinib
-
Hangzhou, Zhejiang, ChinaThe first Affiliated Hospital of Zhejiang University
Oct 18, 2022
Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical
Recruiting
- Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
- topical ruxolitinib 1.5% cream
- Topical vehicle/moisturizer cream
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 20, 2022
Myelofibrosis Trial in United States (Ruxolitinib)
Recruiting
- Myelofibrosis
- Ruxolitinib
-
Boston, Massachusetts
- +4 more
Oct 21, 2022
Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Ruxolitinib
-
Tucson, Arizona
- +1 more
Sep 22, 2022
Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)
Recruiting
- Colorectal Cancer
- Pancreatic Adenocarcinoma
- Trametinib
- Ruxolitinib
-
Singapore, SingaporeNational Cancer Centre
Jun 10, 2022
Lichen Sclerosus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)
Recruiting
- Lichen Sclerosus
- Ruxolitinib cream
- Vehicle cream
-
Birmingham, Alabama
- +4 more
Dec 13, 2022
QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine
Not yet recruiting
- Polycythemia Vera
- Ruxolitinib
- (no location specified)
Sep 30, 2022
Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Steroid Refractory Graft Versus Host Disease
- Cellular Therapy
- Ruxolitinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)
Terminated
- Graft Versus Host Disease
- +2 more
- Ruxolitinib 1.5% cream
- vehicle cream
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2022
Atopic Dermatitis Trial in Montreal (ruxolitinib cream)
Recruiting
- Atopic Dermatitis
- ruxolitinib cream
-
Montreal, Quebec, CanadaInnovoderm Research
Jul 12, 2022
Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)
Enrolling by invitation
- Discoid Lupus Erythematosus
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
May 20, 2022
Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)
Recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
- Ruxolitinib
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
- Ruxolitinib
-
Tampa, Florida
- +4 more
Nov 11, 2022